Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This study evaluates prospectively the effects of an anti-angiotensin II regimen on renal
outcome in patients with mesangioproliferative glomerulonephritis followed-up for 10 years.